Cookies?
Library Header Image
LSE Research Online LSE Library Services

Items where Subject is "R Medicine > RM Therapeutics. Pharmacology"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type
Jump to: A | B | C | D | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W
Number of items at this level: 97.

A

Almond, Stephen and O'Donnell, Owen (2000) Cost analysis of the treatment of schizophrenia in the UK: a a simulation model comparing olanzapine, risperidone and haloperidol. PharmacoEconomics, 17 (4). pp. 383-389. ISSN 1170-7690

B

Brogan, David and Mossialos, Elias (2013) Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model. Globalization and Health, 9 (58). ISSN 1744-8603

Brown, Sally (2014) Book review: The bitterest pills: the troubling story of antipsychotic drugs by Joanna Moncrieff. LSE Review of Books (21 Jan 2014). Blog Entry.

Buskens, Erik, Heeg, Bart M, Knapp, Martin, van Aalast, Gerda, Dries, Pieter J T, de Haan, Lieuwe and van Hout, Ben A (2005) Modelling the treated course of schizophrenia: development of a discrete event simulation model. PharmacoEconomics, 23 (s1). pp. 17-33. ISSN 1170-7690

C

Campbell, Catherine and Foulis, C. (2004) Creating contexts for effective home-based care of people living with HIV/AIDS. Curationis, 27 (3). pp. 5-14. ISSN 0379-8577

Clare, Linda, Kudlicka, Aleksandra, Oyebode, Jan R., Jones, Roy W., Bayer, Antony, Leroi, Iracema, Kopelman, Michael, James, Ian A., Culverwell, Alison, Pool, Jackie, Brand, Andrew, Henderson, Catherine, Hoare, Zoe, Knapp, Martin, Morgan-Trimmer, Sarah, Burns, Alistair, Corbett, Anne, Whitaker, Rhiannon and Woods, Bob (2019) Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT. Health technology assessment (Winchester, England), 23 (10). pp. 1-242. ISSN 2046-4924

Cornford, Tony (2017) The digital future beyond the pill. Delivering Digital Drugs (10 May 2017). Blog Entry.

Costa-Font, Joan and McDaid, David (2006) Pharmaceutical policy reform in Spain. Eurohealth, 12 (4). pp. 14-17. ISSN 1356-1030

Costa-i-Font, Joan (2015) Parallel trade in medicinal drugs is putting the welfare of EU patients at risk. LSE European Politics and Policy (EUROPP) Blog (20 Mar 2015). Blog Entry.

Coulter, Steve (2014) The war over drugs: what’s at stake? LSE New European Trade Unions (03 Jun 2014). Blog Entry.

D

Dickson, Jane (2016) $1 million for a drug used once. Delivering Digital Drugs (10 May 2016). Blog Entry.

Dickson, Jane (2015) Enduring and emerging challenges of informed consent. Delivering Digital Drugs (13 Mar 2015). Blog Entry.

Dickson, Jane (2015) Personalized medicine: a podcast. Delivering Digital Drugs (13 Mar 2015). Blog Entry.

Dickson, Jane (2015) Stratified medicine in 2015 – Leeds Christmas lecture. Delivering Digital Drugs (19 Dec 2015). Blog Entry.

Dickson, Jane (2017) Vocal biomarkers: diagnostics through human voice. Delivering Digital Drugs (17 Feb 2017). Blog Entry.

Dickson, Jane (2017) Warfarin history timeline. Delivering Digital Drugs (15 May 2017). Blog Entry.

Dickson, Jane (2015) A decision support tool for warfarin prescribing. Delivering Digital Drugs (13 Feb 2015). Blog Entry.

Duggan, Andy, Warner, Juliet, Knapp, Martin and Kerwin, Robert (2003) Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. British Journal of Psychiatry, 182 (6). pp. 505-508. ISSN 0007-1250

F

Feliu-Soler, Albert, Borràs, Xavier, Peñarrubia-María, María T., Rozadilla-Sacanell, Antoni, D’Amico, Francesco, Moss-Morris, Rona, Howard, Matthew A., Fayed, Nicolás, Soriano-Mas, Carles, Puebla-Guedea, Marta, Serrano-Blanco, Antoni, Pérez-Aranda, Adrián, Tuccillo, Raffaele and Luciano, Juan V. (2016) Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study). BMC Complementary and Alternative Medicine, 16 (1). ISSN 1472-6882

Fernández, José-Luis, Montgomery, Stuart and Francois, Clément (2005) Evaluation of the cost effectiveness of Escitalopram versus Venlafaxine XR in major depressive disorder. PharmacoEconomics, 23 (2). pp. 155-167. ISSN 1170-7690

G

Ghabri, Salah, Stevenson, Matt, Möller, Jörgen and Caro, J. Jaime (2018) Trusting the results of model-based economic analyses: is there a pragmatic validation solution? PharmacoEconomics. ISSN 1170-7690

Gill, Jennifer, Kanavos, Panos, d'Angela, Daniela, Berger, Karin, Dank, Magdolna, Duncombe, Robert, Fink-Wagner, Antje, Hutton, John, Kossler, Ingrid, Podrazilova, Katerina and Thomas, Michael (2018) RWE in Europe Paper IV: Engaging pharma in the RWE Roadmap. . London School of Economics, London, UK.

Greenan, Caroline, Murphy, Lynn, Yu, Ly-Mee, Kehoe, Patrick G., Coulthard, Elizabeth, Bath, Philip, Stewart, Robert, Jones, Rob, Corbett, Anne, Thomas, Alan, Connelly, Peter, Arrojo, Frank, Canning, Rachel, Wallach, Sylvia, Henderson, Catherine, McGuinness, Bernadette, O’Sullivan, Mike, Holmes, Clive, Knapp, Martin, Ballard, Clive and Passmore, Peter (2016) A randomised controlled trial of calcium channel blockade (CCB) with amlodipine for the treatment of subcortical ischaemic vascular dementia (AFFECT): study protocol. Trials, 17 (1). ISSN 1745-6215

Gyawali, Bishal, Ferrario, Alessandra, van Teijlingen, Edwin and Kallestrup, Per (2016) Challenges in diabetes mellitus type 2 management in Nepal: a literature review. Global Health Action, 9 (1). ISSN 1654-9716

H

Hamilton, Zoe and Munger, Anne (2016) Rhetoric vs reality: contraception in India and the DMPA debate. South Asia @ LSE (15 Sep 2016). Blog Entry.

Helfer, Ana Paula, Camargo, Aline Lins, Tavares, Noemia Urruth Leão, Kanavos, Panos and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de Salud Pública / Pan American Journal of Public Health, 31 (3). pp. 225-232. ISSN 1020-4989

Hibberd, Ralph (2016) Accelerating access to new drugs in Japan. Delivering Digital Drugs (11 May 2016). Blog Entry.

Hibberd, Ralph (2017) Brexit and the falsified medicines directive. Delivering Digital Drugs (17 Feb 2017). Blog Entry.

Hibberd, Ralph (2016) Combating falsified medicines in Africa through digital artefacts. Delivering Digital Drugs (27 Sep 2016). Blog Entry.

Hibberd, Ralph (2016) Hub and spoke dispensing: privacy and sociotechnical rigidity. Delivering Digital Drugs (08 Jul 2016). Blog Entry.

Hibberd, Ralph (2016) Hub and spoke dispensing: safety and sociotechnical pliability. Delivering Digital Drugs (07 Jul 2016). Blog Entry.

Hong, Jihyung, Dilla, Tatiana and Arellano, Jorge (2009) A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain. BMC Psychiatry, 9 (1). p. 15. ISSN 1471-244X

Howard, Robert, Cort, Elizabeth, Bradley, Rosie, Harper, Emma, Kelly, Linda, Bentham, Peter, Ritchie, Craig, Reeves, Suzanne, Fawzi, Waleed, Livingston, Gill, Sommerlad, Andrew, Oomman, Sabu, Nazir, Ejaz, Nilforooshan, Ramin, Barber, Robert, Fox, Chris, Macharouthu, Ajay, Ramachandra, Pranathi, Pattan, Vivek, Sykes, John, Curran, Valerie, Katona, Cornelius, Dening, Tom, Knapp, Martin, Romeo, Renee and Gray, Richard (2018) Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT. Health Technology Assessment, 22 (67). vii-60. ISSN 1366-5278

I

Izugbara, Chimaraoke O. and Wekesa, Eliud (2011) Beliefs and practices about antiretroviral medication: a study of poor urban Kenyans living with HIV/AIDS. Sociology of Health and Illness, 33 (6). pp. 869-883. ISSN 0141-9889

J

Jones, Daniel A., Whittaker, Peter, Rathod, Krishnaraj S., Richards, Amy J., Andiapen, Mervyn, Antoniou, Sotiris, Mathur, Anthony and Ahluwalia, Amrita (2019) Sodium nitrite–mediated cardioprotection in primary percutaneous coronary intervention for ST-Segment Elevation Myocardial Infarction: a cost-effectiveness analysis. Journal of Cardiovascular Pharmacology and Therapeutics, 24 (2). pp. 113-119. ISSN 1074-2484

Jones, Rob, Sheehan, Bart, Phillips, Patrick and Knapp, Martin (2009) DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease: a multicentre RCT. Trials, 10 (57). ISSN 1745-6215

Juul, Sissel, Nielsen, Christine J. F., Labouriau, Rodrigo, Roy, Amit, Tesauro, Cinzia, Jensen, Pia W., Harmsen, Charlotte, Kristoffersen, Emil L., Chiu, Ya-Ling, Frøhlich, Rikke, Fiorani, Paola, Cox-Singh, Janet, Tordrup, David, Koch, Jørn, Bienvenu, Anne-Lise, Desideri, Alessandro, Picot, Stephane, Petersen, Eskild, Leong, Kam W., Ho, Yi-Ping, Stougaard, Magnus and Knudsen, Birgitta R. (2012) Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing plasmodium parasites based on enzyme activity measurement. Acs Nano, 6 (12). pp. 10676-10683. ISSN 1936-0851

K

Kanavos, Panos (1999) Financing pharmaceuticals in transition. Croatian Medical Journal, 40 (June). pp. 244-259. ISSN 0353-9504

Kanavos, Panos, Costa-i-Font, Joan and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence. Economic Policy, 23 (55). pp. 499-544. ISSN 0266-4658

Kanavos, Panos and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe. Scrip reports. Scrip, London.

Kanavos, Panos and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences. Significance, 8 (1). pp. 15-18. ISSN 1740-9705

Kapczynski, Amy, Sampat, Bhaven N. and Shadlen, Kenneth C. (2017) Trade agreements, patents, and drug prices: continuing the debate. Research Paper (572). John M. Olin Center for Studies in Law, Economics, and Public Policy, Yale Law School, New Haven, CT.

Kelm, M., Goubergrits, L., Bruening, J., Yevtushenko, P., Fernandes, J. F., Sündermann, S. H., Berger, F., Falk, V., Kuehne, T., Nordmeyer, S., Morley-Fletcher, E., De Maldè, M., Muthurangu, V., Khushnood, A., Chinali, M., Pongiglione, G., Hennemuth, A., Mirzae, H., Neugebauer, M., Ecabert, O., Neumann, D., Groenenboom, P., Plank, G., Manset, D., McGuire, A., Naci, H. and Salcher, M. (2019) Publisher correction: model-based therapy planning allows prediction of haemodynamic outcome after aortic valve replacement. Scientific Reports, 9 (1). ISSN 2045-2322

King, Derek, Knapp, Martin, Thomas, P., Razzouk, D., Loze, J.-Y., Kan, H.J. and van Baardewijk, M. (2011) Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study. Current Medical Research and Opinion, 27 (2). pp. 365-374. ISSN 0300-7995

Knapp, Martin, King, Derek, Pugner, Klaus and Lapuerta, Pablo (2004) Non-adherence to antipsychotic medication regimens: associations with resource use and costs. British Journal of Psychiatry, 184 (6). pp. 509-516. ISSN 0007-1250

Knapp, Martin, Locklear, Julie and Jarbrink, Krister (2009) Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Current Medical Research and Opinion, 25 (7). pp. 1593-1603. ISSN 0300-7995

Knapp, Martin, McDaid, David and Park, A-La (2015) Recovery and economics. Die Psychiatrie, 12 (3). pp. 162-166. ISSN 1614-4864

Knapp, Martin, Windmeijer, Frank, Brown, Jacqueline, Kontodimas, Stathis, Tzivelekis, Sypros, Haro, Josep Maria, Ratcliffe, Mark, Hong, Jihyung and Novick, Diego (2008) Cost-utility analysis of treatment with Olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the Pan-European SOHO study. PharmacoEconomics, 26 (4). pp. 341-358. ISSN 1170-7690

Kravdal, Øystein and Grundy, Emily (2014) Underuse of medication for circulatory disorders among unmarried women and men in Norway? BMC Pharmacology and Toxicology, 15 (1). p. 65. ISSN 2050-6511

Kwong, Danica, Ferrario, Alessandra, Adamski, Jajub, Inotai, Andras and Kalo, Zoltan (2014) Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. Eurohealth, 20 (2). pp. 25-28. ISSN 1356-1030

L

Le Grand, Julian (1997) Afterword. In: Oakley, Ann and Ashton, John, (eds.) The Gift Relationship: From Human Blood to Social Policy. London School of Economics and Political Science, London, UK. ISBN 0753012014

Levin, David and Shiner, Michael (2016) New deviancy theory and the healthcare system's role in creating, labeling, and facilitating unauthorized prescription drug “abuse”. Pain Practice, 16 (7). pp. 791-793. ISSN 1530-7085

Lichtner, Valentina (2016) ‘the little liar’ – patient information about medicines. Delivering Digital Drugs (10 May 2016). Blog Entry.

M

Malmström, Rickard E., Godman, Brian B., Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Ferrario, Alessandra, Finlayson, Alexander E., Fürst, Jurij, Garuoliene, Kristina, Gomes, Miguel, Gutiérrez-Ibarluzea, Iñaki, Haycox, Alan, Hviding, Krystyna, Herholz, Harald, Hoffmann, Mikael, Jan, Saira, Jones, Jan, Joppi, Roberta, Kalaba, Marija, Kvalheim, Christina, Laius, Ott, Langner, Irene, Lonsdale, Julie, Lööv, Sven-Äke, Malinowska, Kamila, McCullagh, Laura, Paterson, Ken, Markovic-Pekovic, Vanda, Martin, Andrew, Piessnegger, Jutta, Selke, Gisbert, Sermet, Catherine, Simoens, Steven, Tulunay, Cankat, Tomek, Dominik, Vončina, Luka, Vlahovic-Palcevski, Vera, Wale, Janet, Wilcock, Michael, Wladysiuk, Magdalena, Woerkom, Menno van, Zara, Corrine and Gustafsson, Lars L. (2013) Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Frontiers in Pharmacology, 4 (39). ISSN 1663-9812

Manfrin, Andrea, Tinelli, Michela, Thomas, Trudy and Krska, Janet (2017) A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Services Research, 17 (300). ISSN 1472-6963

Massard da Fonseca, Elize, Shadlen, Kenneth C. and Inácio Bastos, Francisco (2019) Brazil’s fight against Hepatitis C: universalism, local production, and patents. New England Journal of Medicine, 380 (7). pp. 605-607. ISSN 0028-4793

McCrone, Paul R., Chisholm, Daniel, Knapp, Martin, Hughes, Richard, Comi, Giancarlo, Dalakas, Marinos C., Illa, Isabel, Kilindireas, Costas, Nobile-Orazio, Eduardo, Swan, Anthony Victor, Van den Bergh, Peter and Willison, Hugh J. (2003) Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. European Journal of Neurology, 10 (6). pp. 687-694. ISSN 1468-1331

McCrone, Paul R., Weeramanthri, Tara, Knapp, Martin R.J., Rushton, Alan, Trowell, Judith, Miles, Gillian and Kolvin, Israel (2005) Cost-effectiveness of individual versus group psychotherapy for sexually abused girls. Child and Adolescent Mental Health, 10 (1). pp. 26-31. ISSN 1475-3588

McGuire, Alistair (2012) The European value-pricing game. Expert Review of Pharmacoeconomics and Outcomes Research, 12 (1). pp. 5-6. ISSN 1473-7167

McGuire, Alistair, Burke, T., Goldstein, J., Maniadakis, N. and Pettitt, D. (2000) Overview of the Arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib. British Journal of Rheumatology, 39 (s2). pp. 33-42. ISSN 1462-0324

Morais de Oliveira, Iago (2016) Using international human rights law to guarantee the right to health: a Brazilian experience. LSE Human Rights Blog (13 Dec 2016). Blog Entry.

N

Naci, Huseyin (2019) Impact of predictive medicine on therapeutic decision making: a randomized controlled trial in congenital heart disease. npj Digital Medicine. ISSN 2398-6352 (In Press)

Naci, Huseyin (2011) The increasing need to harmonize evidence demands of regulators, payers, and health technology assessment bodies in Europe – opportunities and challenges. ISPOR Connections, 17 (4). pp. 4-6. ISSN 1538-5108

Naci, Huseyin, Salcher-Konrad, Maximilian, Dias, Sofia, Blum, Manuel R., Sahoo, Samali Anova, Nunan, David and Ioannidis, John P. A. (2018) How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 RCTs assessing exercise and medication effects on systolic blood pressure. British Journal of Sports Medicine. ISSN 0306-3674

Naci, Huseyin, van Valkenhoef, G., Higgins, J. P. T., Fleurence, R. and Ades, A. E. (2014) Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs. Circulation: Cardiovascular Quality and Outcomes, 7 (5). pp. 787-792. ISSN 1941-7705

O

O'Neill, Rachel (2014) As if gender mattered: reconsidering the implications of ‘intoxicating stories’. International Journal of Drug Policy, 25 (3). pp. 356-357. ISSN 0955-3959

Owen, Geoffrey (2016) Biotechnology: Why is Europe lagging behind the U.S.? Management with Impact (07 Nov 2016). Blog Entry.

P

Park, A-La and McDaid, David (2012) Economic modelling of mindfulness meditation for people with mental health problems. In: International Research Congress on Integrative Medicine and Health, 2012-05-15 - 2012-05-18.

R

Ragan, C. Ian, Bard, Imre ORCID: 0000-0001-6395-0335 and Singh, Ilina (2013) What should we do about student use of cognitive enhancers?: an analysis of current evidence. Neuropharmacology, 64. pp. 588-595. ISSN 0028-3908

Randell, Elizabeth, McNamara, Rachel, Delport, Sue, Busse, Monica, Hastings, Richard P., Gillespie, David, Williams-Thomas, Rhys, Brookes-Howell, Lucy, Romeo, Renee, Boadu, Janet, Ahuja, Alka S., McKigney, Anne Marie, Knapp, Martin, Smith, Kathryn, Thornton, Jacqui and Warren, Gemma (2019) Sensory integration therapy versus usual care for sensory processing difficulties in autism spectrum disorder in children: study protocol for a pragmatic randomised controlled trial. Trials, 20 (1). ISSN 1745-6215

Rogeberg, Ole, Bergsvik, Daniel, Phillips, Lawrence D., Amsterdam, Jan van, Eastwood, Niamh, Henderson, Graeme, Lynskey, Michael, Measham, Fiona, Ponton, Rhys, Rolles, Steve, Schlag, Anne Katrin, Taylor, Polly and Nutt, David (2018) A new approach to formulating and appraising drug policy: a multi-criterion decision analysis applied to alcohol and cannabis regulation. International Journal of Drug Policy. ISSN 0955-3959

S

Sado, Mitsuhiro, Knapp, Martin, Yamauchi, Keita, Fujisawa, Daisuke, So, Mirai, Nakagawa, Atsuo, Kikuchi, Toshiaki and Ono, Yutaka (2009) Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan. Australian and New Zealand Journal of Psychiatry, 43 (6). pp. 539-547. ISSN 0004-8674

Salas-Vega, Sebastian, Iliopoulos, Othon and Mossialos, Elias (2017) Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines. JAMA Oncology, 3 (3). pp. 382-390. ISSN 2374-2437

Shadlen, Kenneth C. (2013) Learning from India? A new approach to secondary pharmaceutical patents. South Asia @ LSE (03 May 2013). Blog Entry.

Shadlen, Kenneth C. and Sampat, Bhaven N. (2015) Drug patenting in India: looking back and looking forward. South Asia @ LSE (09 Nov 2015). Blog Entry.

Shadlen, Kenneth C., Sampat, Bhaven N. and Amin, Tahir M. (2012) Balancing innovation and access: India’s pharmaceutical patent laws. South Asia @ LSE (23 Jul 2012). Blog Entry.

Singh, Ilina (2008) Beyond polemics: science and ethics of ADHD. Nature Reviews Neuroscience, 9 (12). pp. 957-964. ISSN 1471-003X

Sorenson, Corinna, Naci, Huseyin, Cylus, Jonathan and Mossialos, Elias (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British Medical Journal, 343 (7822). d4849-d4849. ISSN 0959-8138

Surguladze, Simon, Patel, Anita, Kerwin, Robert W, Knapp, Martin and Travis, Michael J (2005) Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29 (4). pp. 517-522. ISSN 0278-5846

T

Tervonen, Tommi, Angelis, Aris, Hockley, Kimberley, Pignatti, Francesco and Phillips, Lawrence D. (2019) Quantifying preference in drug benefit-risk decisions. Clinical Pharmacology and Therapeutics. ISSN 0009-9236

Tinelli, Michela (2001) Menopausa e terapia ormonale sostitutiva: qualità di vita e farmacoeconomia. Farmacoeconomia News, 3. pp. 15-20. ISSN 1126-4705

Tinelli, Michela (2001) Progetto pilota per la rilevazione delle prescrizioni farmaceutiche in Farmacia. Cronache Farmaceutiche, 4. pp. 200-204. ISSN 0011-1783

Tinelli, Michela, Blenkinsopp, Alison and Bond, Christine (2011) Development, validation and application of a patient satisfaction scale for a community pharmacy medicines-management service. International Journal of Pharmacy Practice, 19 (3). pp. 144-155. ISSN 0961-7671

Towse, A, Drummond, Michael and Sorenson, Corinna (2012) Measuring value: pharmacoeconomics theory and practice. In: Danzon, Patricia M. and Nicholson, Sean, (eds.) Oxford Handbook on the Economics of the Biopharmaceutical Industry. Oxford University Press, Oxford, UK, pp. 394-437. ISBN 9780199742998 (Submitted)

Towse, Adrian, Drummond, Michael and Sorenson, Corinna (2011) Measuring value: pharmacoeconomics in theory and practice. Occasional paper (11/03). Office of Health Economics.

Tzouma, Victoria, Grepstad, Mari, Grimaccia, Federico and Kanavos, Panos (2015) Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Therapeutic Innovation and Regulatory Science, 49 (6). pp. 947-956. ISSN 2168-4790

V

Vandoros, Sotiris (2014) Therapeutic substitution post-patent expiry: the cases of ace inhibitors and proton pump inhibitors. Health Economics, 23 (5). pp. 621-630. ISSN 1057-9230

Vandoros, Sotiris and Kanavos, Panos (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied Economics, 45 (22). pp. 3230-3239. ISSN 0003-6846

Vandoros, Sotiris and Stargardt, Tom (2013) Reforms in the Greek pharmaceutical market during the financial crisis. Health Policy, 109 (1). pp. 1-6. ISSN 0168-8510

Varol, Nebibe, Costa-i-Font, Joan and McGuire, Alistair (2012) Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34 (3). pp. 531-553. ISSN 2040-5790

Vermersch, Patrick, Martinelli, Vittorio, Pfleger, Claudia, Rieckmann, Peter, Alonso-Magdalena, Lucia, Galazka, Andrew, Dangond, Fernando and Phillips, Lawrence D. (2019) Benefit-risk assessment of cladribine using multi-criteria decision analysis (MCDA) for patients with relapsing-remitting multiple sclerosis. Clinical Therapeutics, 41 (2). pp. 249-260. ISSN 0149-2918

Visintin, Erica, Tinelli, Michela and Kanavos, Panos (2019) Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries. Health Policy, 123 (2). pp. 118-129. ISSN 0168-8510

W

Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin (2018) The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation. Clinical Trials, 15 (3). pp. 243-246. ISSN 1740-7745

Wekesa, Eliud and Coast, Ernestina (2013) Living with HIV in Kenyan slums in an era of anti-retroviral therapy (ART). Africa at LSE Blog (03 May 2013). Blog Entry.

Williams, Thomas Christie (2017) Long read review: drug dealer, MD: how doctors were duped, patients got hooked and why it’s so hard to stop by Anna Lembke. LSE Review of Books (22 Mar 2017). Blog Entry.

Wouters, Olivier J., Kanavos, Panos G. and McKee, Martin (2017) Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. Milbank Quarterly, 95 (3). pp. 554-601. ISSN 0887-378X

Wouters, Olivier J., O'Donoghue, Donal J., Ritchie, James, Kanavos, Panos G. and Narva, Andrew S. (2015) Early chronic kidney disease: diagnosis, management and models of care. Nature Reviews Nephrology, 11 (8). pp. 491-502. ISSN 1759-5061

This list was generated on Fri May 24 13:39:27 2019 BST.